Updated May 2026 | The Department of Justice reports that Camp Lejeune settlement offers have exceeded $794 million, with $543 million already paid out as of April 16, 2026. March 2026 alone saw $175 million in new settlement offers approved in three weeks. Bellwether trials — expected to begin in late 2026 or early 2027 — will determine how much the government pays thousands of remaining claimants. If you lived or served at Camp Lejeune between 1953 and 1987, here is where things stand.
Between August 1953 and December 1987, approximately one million people lived, worked, and served at Marine Corps Base Camp Lejeune in Jacksonville, North Carolina. During that entire period, they drank water, cooked with it, bathed their children in it, and trusted that the most basic necessity of life on a military installation was safe.
It was not.
The water systems at Camp Lejeune — particularly Hadnot Point and Tarawa Terrace — were contaminated with some of the most hazardous industrial chemicals known: trichloroethylene (TCE), a dry cleaning solvent and industrial degreaser; perchloroethylene (PCE), another solvent used in dry cleaning operations on the base; benzene, a known human carcinogen; and vinyl chloride, a breakdown product of TCE and PCE that is one of the most potent carcinogens in the industrial chemical catalog.
For over three decades, Marines, their spouses, their children — and the civilian workers who maintained the base — drank, cooked with, and bathed in this contaminated water. Many of them developed cancers and serious diseases years or decades later. Many of them died without ever knowing the connection.
For most of that time, the law gave them no recourse against the federal government. Then, in August 2022, President Biden signed the PACT Act — which included the Camp Lejeune Justice Act (CLJA) — creating the first viable legal pathway for Camp Lejeune victims to seek compensation from the U.S. government.
As of May 2026, over 409,000 administrative claims have been filed. More than 3,700 federal lawsuits are pending in the Eastern District of North Carolina. The government has paid out over $543 million and extended offers exceeding $794 million. And the most consequential phase — bellwether trials that will establish how much the government must pay thousands of remaining claimants — is approaching.
What Happened at Camp Lejeune — The Complete Picture
The contamination timeline:
Between 1953 and 1987, four primary volatile organic compounds (VOCs) contaminated Camp Lejeune’s drinking water at levels the EPA considers harmful:
Trichloroethylene (TCE): A solvent used extensively in metal degreasing and industrial cleaning. The primary source at Camp Lejeune was a military dry cleaning facility. At peak contamination, TCE levels in the Hadnot Point water system reached 1,400 parts per billion — more than 280 times the current EPA safety limit of 5 ppb.
Perchloroethylene (PCE): Another industrial solvent used in dry cleaning. PCE contamination at Tarawa Terrace came primarily from ABC One-Hour Cleaners, an off-base dry cleaning facility whose waste infiltrated the water supply. Peak PCE levels reached 215 parts per billion — over 40 times the current EPA limit.
Benzene: A human carcinogen produced as a breakdown product of TCE and PCE and from other sources. Benzene has no safe exposure threshold and is directly linked to leukemia.
Vinyl Chloride: The most dangerous of the contaminants — a Group 1 carcinogen that requires zero exposure to eliminate cancer risk. Vinyl chloride forms when TCE and PCE break down in soil and groundwater.
Who was exposed:
The contamination affected:
- On-base water systems — Hadnot Point served barracks, the hospital, and family housing. Tarawa Terrace served primarily family housing. Holcomb Boulevard served newer sections of the base.
- The timing of contamination varied by water system — Tarawa Terrace contamination was heaviest from approximately 1957 through 1985, while Hadnot Point was contaminated throughout much of the 1953–1987 window.
- All people on base who consumed water from these systems — Marines, Navy personnel, Marine Corps family members, civilian employees and contractors, and babies born to pregnant women stationed there.
Why it took so long:
TCE, PCE, benzene, and vinyl chloride are odorless, colorless, and tasteless at the concentrations present in Camp Lejeune’s water. There was no way for residents to detect the contamination through the senses. The government conducted internal testing beginning in the early 1980s that identified contamination — and did not fully inform residents or stop the use of contaminated wells until 1985 for some systems and later for others.
The health consequences:
The disease clusters that emerged in former Camp Lejeune residents over the following decades are what eventually forced legislative action. Veterans, former dependents, and civilian workers developed leukemia, bladder cancer, kidney cancer, Parkinson’s disease, non-Hodgkin’s lymphoma, and other serious conditions at rates substantially above background populations. Children born at Camp Lejeune suffered neural tube defects, childhood cancers, and other birth-related harms.
The Legal Framework — The PACT Act and the Camp Lejeune Justice Act
For decades, Camp Lejeune victims had no legal recourse against the federal government. North Carolina’s statute of repose — a 10-year hard cap on filing a claim regardless of when the harm was discovered — blocked virtually all lawsuits. Victims had no path to compensation.
The PACT Act of 2022 changed this by including the Camp Lejeune Justice Act (CLJA) — a provision specifically creating a legal right for Camp Lejeune victims to sue the federal government under a lowered causation standard.
The key legal innovations of the CLJA:
1. Eliminating the statute of limitations barrier: The CLJA created a new filing window — originally with a two-year deadline from enactment (August 10, 2024) — specifically for Camp Lejeune claims that were previously barred by North Carolina law. Claims could be filed regardless of when the injury occurred.
2. Lowering the causation standard: Standard tort law requires plaintiffs to prove their injury was “more likely than not” caused by the defendant’s conduct. The CLJA created a modified standard: plaintiffs must show that the contaminated water at Camp Lejeune “can cause” the type of harm alleged (general causation) and that their specific exposure was sufficient to create a risk of harm that may have contributed to their condition. This is a meaningful accommodation for cases where the latency period between exposure and disease makes precise causation difficult.
3. Waiving sovereign immunity: The U.S. government generally cannot be sued without its consent. The CLJA was an explicit congressional waiver of sovereign immunity for these specific claims — a recognition that the government’s own negligence in contaminating Camp Lejeune’s water supply created a legal obligation to compensate victims.
CRITICAL: The CLJA administrative filing deadline has passed. The deadline for filing administrative claims with the Department of the Navy was August 10, 2024. New administrative claims are no longer being accepted. However:
- People who filed before August 10, 2024 retain their rights to pursue claims
- Those whose administrative claims were not resolved have the right to file federal lawsuits in the Eastern District of North Carolina
- The VA healthcare and disability benefits established under the broader PACT Act are SEPARATE from the lawsuit process and remain available to eligible veterans
The Camp Lejeune Litigation Status — May 2026
The Administrative Track — Elective Option Settlements
The Department of the Navy established the Elective Option (EO) — an administrative settlement program designed to resolve claims faster than federal court litigation. Under the EO, claimants with qualifying conditions receive settlement offers based on:
Tier 1 conditions (strongest causation evidence):
- Bladder cancer
- Non-Hodgkin’s lymphoma
- Adult leukemia (excluding CLL)
- Multiple myeloma
- Kidney cancer/renal toxicity
- Parkinson’s disease
Tier 2 conditions:
- Esophageal cancer
- Breast cancer
- Lung cancer
- Hepatic steatosis (fatty liver)
- Female infertility
- Miscarriage
- Neurobehavioral effects
- Scleroderma
Settlement amount structure:
The EO settlement amounts scale based on:
- Disease tier (Tier 1 pays more than Tier 2)
- Exposure duration (longer time at Camp Lejeune = higher settlement)
- 30 days to 1 year: Lower payout range
- 1–5 years: Mid-range payouts
- 5+ years: Maximum payouts
Published range: $100,000 to $550,000 for EO settlements depending on tier and exposure duration. A veteran stationed at Camp Lejeune for the full period and diagnosed with Tier 1 kidney cancer is at the high end; a family member with 6 months of exposure and a Tier 2 condition is at the low end.
The critical choice: Accept the EO or litigate in federal court?
Claimants offered an Elective Option settlement have 60 days to accept or decline. Accepting provides faster payment — but locks in the settlement formula. Declining preserves the right to litigate in federal court, where individual case values may be substantially higher — but timelines are significantly longer, and outcomes are less certain.
What the experts say: Attorney analysis suggests that claimants with strong cases — Tier 1 diseases, long exposure periods, strong documentation — are often advised to consider declining the EO in favor of federal litigation, where bellwether trial outcomes may establish higher compensation ranges. Claimants who are elderly or in declining health, or who need immediate financial relief, may be better served by the EO’s faster timeline.
The Federal Litigation Track — Bellwether Trials Approaching
As of May 2026:
- 3,700+ federal lawsuits pending in the Eastern District of North Carolina
- 409,910 administrative claims still pending before the Department of the Navy
- $794 million in settlement offers extended as of April 16, 2026
- $543 million in payments made as of April 16, 2026
- March 2026: DOJ approved 600+ settlement offers worth $175 million in three weeks alone
Track 1 cases:
Twenty-five carefully selected cases — involving plaintiffs with the five conditions best supported by science (bladder cancer, kidney cancer, leukemia, non-Hodgkin’s lymphoma, and Parkinson’s disease) — have been designated as Track 1 bellwether cases. These cases will be among the first to go to trial, with their outcomes shaping the settlement matrix for all other claimants.
March 2026 — Government expert kicked out:
In March 2026, a significant ruling in the Camp Lejeune litigation saw a government expert witness excluded — a meaningful procedural victory for plaintiffs in the ongoing battle over causation science. The government has been aggressively challenging plaintiffs’ experts on causation methodology, and the exclusion of one of their own witnesses signals the court’s scrutiny of both sides’ scientific evidence.
Trial timing:
Plaintiff attorneys have been pushing hard for trials to begin in 2026 — emphasizing that many victims are elderly and cannot afford further delays. The government has repeatedly requested additional time. The current expectation is that bellwether trials will begin in late 2026 or early 2027.
Court-ordered mediation continues: Both parties are actively engaged in mediation facilitated by the court. A global settlement — which would resolve the majority of the 409,000+ claims through a structured compensation program — remains a possibility, particularly after bellwether trials establish the jury award range.
Who Qualifies for Camp Lejeune Compensation in 2026?
Eligibility requirements:
1. Physical presence at Camp Lejeune, North Carolina: You (or the person you represent) must have lived, worked, or been otherwise physically present at Camp Lejeune for at least 30 days during the contamination period — August 1, 1953 through December 31, 1987.
Who qualifies by category:
- Active duty Marines and Navy personnel
- National Guard and Reserve members who served at Camp Lejeune
- Military family members (spouses, children) who lived on base
- Civilian employees and contractors who worked on base
- Babies born to mothers who were pregnant while at Camp Lejeune (separate in utero claims)
- The estates of deceased individuals who died from qualifying conditions
2. Qualifying illness or harm:
Your condition must be one that the scientific literature links to exposure to TCE, PCE, benzene, or vinyl chloride. The Tier 1 and Tier 2 categories (above) define the current litigation framework.
Tier 1 qualifying conditions (strongest causation evidence, highest settlements):
- Bladder cancer
- Non-Hodgkin’s lymphoma
- Leukemia (adult non-lymphocytic)
- Multiple myeloma
- Kidney cancer / renal disease
- Parkinson’s disease
Tier 2 qualifying conditions (moderate to strong causation evidence):
- Esophageal cancer
- Breast cancer
- Lung cancer
- Hepatic steatosis
- Neurobehavioral effects
- Female infertility / miscarriage
- Scleroderma
In utero exposure claims: Children born to mothers who were pregnant while residing at Camp Lejeune have separate claims for conditions caused by in utero exposure to the contaminants — including childhood cancers, birth defects, neurological conditions, and developmental delays.
What documentation is needed:
Exposure documentation:
- Military service records (DD-214) showing assignments to Camp Lejeune
- Base housing records confirming on-base residence
- Employment records for civilian workers
- VA records referencing Camp Lejeune service
- Family member documentation connecting to the service member’s Camp Lejeune assignment
Medical documentation:
- Diagnosis records confirming the qualifying condition
- Pathology reports for cancer diagnoses
- Treatment records (oncology, neurology)
- Death certificates for wrongful death claims
The documentation challenge: Exposure records from the 1950s through 1980s are often incomplete, archived in federal systems, or unavailable from individual records. Experienced Camp Lejeune attorneys have established procedures for accessing military records, VA databases, and base housing records that most claimants cannot obtain independently.
VA Benefits vs. Lawsuit Compensation — Understanding Both Paths
One of the most important aspects of the PACT Act that many veterans and family members don’t fully understand is that VA healthcare and disability benefits are SEPARATE from and do not reduce your Camp Lejeune lawsuit settlement.
VA healthcare expansion (PACT Act): Veterans who served at Camp Lejeune for 30+ days during the contamination period are now eligible for VA healthcare for any of 15 qualifying conditions — at no cost to the veteran, regardless of whether the condition is formally “service-connected” through the disability rating process.
VA disability compensation: Veterans can pursue a disability rating for conditions linked to Camp Lejeune exposure through the VA’s standard disability claims process. A successful rating produces monthly disability payments that continue for life.
The lawsuit: Under the CLJA, your lawsuit compensation is separate from and does not offset your VA benefits in most circumstances. The government has contested this in litigation (arguing that VA payments should reduce lawsuit payouts), and the offset question is one of the pending legal issues in the Track 1 cases. Current guidance from plaintiff attorneys: pursue both VA benefits and lawsuit claims independently — let the court resolve the offset question.
The Settlement Value Analysis — What Cases Are Worth
Elective Option (Administrative) Settlements:
Published payout range: $100,000 to $550,000 based on tier and exposure duration. The DOJ’s acceleration in early 2026 — $175 million approved in three weeks in March alone — signals that the administrative program is moving toward resolution of a larger share of the 400,000+ pending administrative claims.
Federal Court Litigation:
No jury has yet decided a Camp Lejeune case. The Track 1 bellwether trials will establish the jury award range that shapes global settlement negotiations. Expert projections for top-tier cases:
| Condition | Exposure Duration | Projected Compensation Range |
|---|---|---|
| Bladder cancer | 5+ years | $250,000 – $1,000,000+ |
| Kidney cancer | 5+ years | $300,000 – $1,000,000+ |
| Non-Hodgkin’s lymphoma | 5+ years | $250,000 – $800,000 |
| Parkinson’s disease | 5+ years | $250,000 – $600,000 |
| Leukemia | 5+ years | $300,000 – $1,000,000+ |
| In utero / birth injury | N/A (mother’s exposure) | $150,000 – $500,000+ |
| Wrongful death (Tier 1) | 5+ years | $350,000 – $1,500,000+ |
The track record so far: The DOJ’s aggressive settlement activity in early 2026 — $543 million paid on roughly 3% of total claims — suggests the government recognizes its legal exposure and is moving to resolve well-documented cases. The remaining 400,000 unresolved claims have a long road, but the bellwether trial outcomes will significantly clarify their value.
The Litigation Challenges — What Makes Camp Lejeune Cases Unique
Government as defendant
Unlike typical mass torts where private corporations are the defendants, Camp Lejeune cases are filed against the United States government. This creates unique procedural requirements:
- Cases are filed under the Federal Tort Claims Act and the CLJA
- The venue is exclusively the Eastern District of North Carolina
- Sovereign immunity waivers created by the CLJA have specific legal parameters
- The government can appeal adverse rulings through different channels than private defendants
The causation battle
The single biggest legal issue in Camp Lejeune litigation is causation: can plaintiffs establish that the contaminated water at Camp Lejeune caused their specific cancer or condition? The government is challenging plaintiffs’ expert testimony on causation methodology across multiple Track 1 disease categories.
The plaintiff side: Decades of epidemiological research, including studies by the Agency for Toxic Substances and Disease Registry (ATSDR), document elevated rates of specific cancers among Camp Lejeune residents compared to control populations. The IARC classifies TCE as a Group 1 human carcinogen (definitively causing kidney cancer). Benzene is a definitively established cause of leukemia.
The government’s strategy: Rather than disputing the underlying science, the government is challenging the legal framework for expert testimony — seeking to exclude plaintiff experts on Daubert grounds, contesting the methodology for establishing causation in individual cases, and arguing for a stricter causation standard than the CLJA’s statutory language supports.
March 2026: The court excluded one of the government’s own expert witnesses — a signal that the Daubert battles are not all going the government’s way.
Frequently Asked Questions
The administrative deadline was August 2024. Have I lost my right to compensation? If you filed an administrative claim before August 10, 2024 — you retain all your rights, including the right to proceed to federal court litigation if your claim is not resolved administratively. If you did not file before August 10, 2024, the CLJA administrative pathway is closed to you. However, you may still be eligible for VA healthcare and disability benefits under the PACT Act, which have no filing deadline. Consult an attorney to evaluate all available options.
I served at Camp Lejeune but my cancer was diagnosed 20 years after I left. Does that affect my case? No. The long latency period between chemical exposure and cancer development is well-documented and accounted for in both the CLJA’s causation framework and the scientific evidence supporting these claims. TCE-related kidney cancer typically has a latency period of 10 to 30+ years. Many claimants are veterans diagnosed with cancer 20 to 40 years after their Camp Lejeune service.
My father served at Camp Lejeune and died of bladder cancer in 2018. Can our family still file? The estate of a deceased victim who had a qualifying condition can potentially pursue a CLJA claim — if the administrative claim was filed before August 10, 2024. If the estate is among the 409,000+ claims pending with the Navy, it can proceed to federal court litigation. For estates where a claim was filed in time, wrongful death compensation is available.
Should I accept the Elective Option settlement or litigate in federal court? This is the most consequential decision in your case and requires individualized legal advice. Generally: claimants with strong documentation, Tier 1 conditions, and long exposure periods often have better potential outcomes in federal court — but face longer timelines. Claimants who are elderly, have deteriorating health, or need faster resolution often find the EO’s certainty valuable despite its lower ceiling. Never decline an EO offer or accept one without consulting your attorney about how it compares to your estimated federal court value.
Is my VA disability compensation reduced if I receive a Camp Lejeune lawsuit settlement? This is the “offset” question — one of the most contested legal issues in the Track 1 cases. The government argues that VA payments should reduce CLJA lawsuit compensation. Plaintiffs argue they should not. Until the court rules on this issue, plaintiff attorneys generally advise pursuing both VA disability compensation and CLJA claims independently, understanding that the offset question will be resolved by litigation.
Bottom Line: The Payments Are Coming — But So Are the Trials
The Camp Lejeune litigation has cleared its most significant hurdle: the PACT Act created the legal right, the administrative program is paying claims, and bellwether trials are approaching that will set the template for the thousands of federal lawsuits still pending.
The numbers speak clearly. March 2026: $175 million in new offers in three weeks. Total paid: $543 million on a fraction of total claims. The Department of Justice’s aggressive settlement pace signals recognition that the government’s legal exposure here is real, documented, and growing.
For people who:
- Lived, worked, or served at Camp Lejeune between 1953 and 1987
- For at least 30 days
- And subsequently developed bladder cancer, kidney cancer, non-Hodgkin’s lymphoma, leukemia, multiple myeloma, Parkinson’s disease, or another qualifying condition
The path to compensation exists — but it requires action. If you filed an administrative claim before August 2024, contact an attorney to understand whether your claim is among those being offered settlements, and whether the Elective Option or federal litigation is the better path for your specific situation. VA healthcare and disability benefits under the PACT Act are available separately and should be pursued regardless of your lawsuit status.
This article is for informational purposes only and does not constitute legal advice. Eligibility, claim status, and settlement amounts vary by individual facts. The CLJA administrative filing deadline has passed. Consult a licensed attorney for guidance specific to your situation.
Last updated: May 2026 | Data sourced from Department of Justice public statements (April 16, 2026), ConsumerNotice MDL tracker, Miller & Zois litigation updates, LawMonarch CLJA analysis, WaterVerge settlement tracking, and verified court filings from the Eastern District of North Carolina